The U.S. digital therapeutics market size was valued at $1.16 billion in 2019 and is expected to reach $5.08 billion by 2027 with a CAGR of 19.2% during the forecast period. Increase in adoption of ...

Treatments emerging from the digital therapeutics space were once greeted with optimism, due to the potential to aid patients’ health through technology, rather than pharmaceuticals. Ben ...

The future use cases for digital therapies One question that will be posed for digital therapeutics is how many different viable treatments areas could be helped or managed by such therapies.

Click Therapeutics has collected a groundbreaking green light from the FDA for the agency’s first prescription digital therapeutic ... paves the way for future development of the program ...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the appointment of ...

a mobile app developed by prescription digital medicines startup Click Therapeutics. The FDA marketing authorization announced Tuesday permits use of the Click digital therapeutic for the ...

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine.

Anaplastic thyroid cancer (ATC), a rare yet highly aggressive malignancy, continues to represent a major clinical challenge.

The Global Generic Drugs Market achieved a valuation of $487.21 Billion in 2024 and is anticipated to exceed $898 Billion by ...

A recent publication in Genes & Diseases has delivered a compelling synthesis of the latest insights into the cellular ...

California Physicians' Service, doing business as Blue Shield of California and Blue Shield Life & Health Insurance Company, ...